MedTrace Logo

A Smoking Cessation Intervention for Yale Dining Employees

NCT02562521 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2018-04-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate a smoking cessation program for employees at the Yale University dining hall. Two pilot dining halls and six paired dining halls (3 test and 3 control sites) will be offered a contingency management/pharmacotherapy smoking cessation intervention at the work site.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Contingency management

Participants in the intervention group will receive a tailored intervention that utilizes contingency management in which they receive monetary rewards for reducing or quitting smoking.

DRUG

Nicotine replacement therapy

Participants have the option of using nicotine patch in combination with nicotine gum or lozenge

DRUG

Varenicline

Individuals who do not respond initially to Nicotine Replacement Therapy will be offered varenicline as an alternative

BEHAVIORAL

Additional behavioral support

Based on interest, participants can be referred to a telephone quitline or receive access to mobile text messaging programs or app based smoking cessation support

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Stephanie O'Malley, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02562521 on ClinicalTrials.gov